-
1
-
-
0036739725
-
A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: The Ziprasidone Extended Use on Schizophrenia (ZEUS) Study
-
Arato M, O'Connor R, Meltzer HY. 2002. A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use on Schizophrenia (ZEUS) Study. Int Clin Psychopharmacol 17:207-215.
-
(2002)
Int Clin Psychopharmacol
, vol.17
, pp. 207-215
-
-
Arato, M.1
O'Connor, R.2
Meltzer, H.Y.3
-
2
-
-
2342451962
-
Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus
-
Bai O, Zhang H, Li XM. 2004. Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain Res 1010:81-86.
-
(2004)
Brain Res
, vol.1010
, pp. 81-86
-
-
Bai, O.1
Zhang, H.2
Li, X.M.3
-
5
-
-
0036379097
-
Chinese classification of mental disorders (CCMD-3): Towards integration in international classification
-
Chen YF. 2002. Chinese classification of mental disorders (CCMD-3): towards integration in international classification. Psychopathology 35:171-175.
-
(2002)
Psychopathology
, vol.35
, pp. 171-175
-
-
Chen, Y.F.1
-
6
-
-
1542373740
-
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies
-
Correll CU, Leucht S, Kane JM. 2004. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry 161: 414-425
-
(2004)
Am J Psychiatry
, vol.161
, pp. 414-425
-
-
Correll, C.U.1
Leucht, S.2
Kane, J.M.3
-
7
-
-
0028200350
-
Clozapine-related tardive dyskinesia
-
Dave M. 1994. Clozapine-related tardive dyskinesia. Biol Psychiatry 35:886-887.
-
(1994)
Biol Psychiatry
, vol.35
, pp. 886-887
-
-
Dave, M.1
-
9
-
-
0016711577
-
Extrapyramidal symptoms following clozapine therapy: Case report
-
Doepp S, Buddeberg C. 1975. Extrapyramidal symptoms following clozapine therapy: case report. Nervenarzt 46:589-590.
-
(1975)
Nervenarzt
, vol.46
, pp. 589-590
-
-
Doepp, S.1
Buddeberg, C.2
-
11
-
-
25444451402
-
Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients
-
Fehsel K, Loeffler S, Krieger K, Henning U, Agelink M, Kolb-Bachofen V, et al. 2005. Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients. J Clin Psychopharmacol 25:419-426
-
(2005)
J Clin Psychopharmacol
, vol.25
, pp. 419-426
-
-
Fehsel, K.1
Loeffler, S.2
Krieger, K.3
Henning, U.4
Agelink, M.5
Kolb-Bachofen, V.6
-
12
-
-
0034116158
-
Prevalence of spontaneous dyskinesia in schizophrenia
-
Fenton WS. 2000. Prevalence of spontaneous dyskinesia in schizophrenia. J Clin Psychiatry 61:10-14.
-
(2000)
J Clin Psychiatry
, vol.61
, pp. 10-14
-
-
Fenton, W.S.1
-
13
-
-
0042973812
-
Three case reports of emergent dyskinesia with clozapine
-
Gafoor R, Brophy J. 2003. Three case reports of emergent dyskinesia with clozapine. Eur Psychiatry 18:260-261.
-
(2003)
Eur Psychiatry
, vol.18
, pp. 260-261
-
-
Gafoor, R.1
Brophy, J.2
-
14
-
-
77951695650
-
Clozapine and tardive dyskinesia: Controlled study
-
Huang JZ, Weng SW, Xie B, Yang XH, Shi SS, Xu YF. 2000. Clozapine and tardive dyskinesia: controlled study. Chin J Nerv Ment Dis 2:113-114.
-
(2000)
Chin J Nerv Ment Dis
, vol.2
, pp. 113-114
-
-
Huang, J.Z.1
Weng, S.W.2
Xie, B.3
Yang, X.H.4
Shi, S.S.5
Xu, Y.F.6
-
15
-
-
0029023056
-
Risk of tardive dyskinesia in older patients: A prospective longitudinal study of 266 patients
-
Jeste DV, Caligiuri MP, Paulsen JS, Heaton RK, Lacro JP, Harris MJ, et al. 1995. Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 patients. Arch Gen Psychiatry 52:756-765.
-
(1995)
Arch Gen Psychiatry
, vol.52
, pp. 756-765
-
-
Jeste, D.V.1
Caligiuri, M.P.2
Paulsen, J.S.3
Heaton, R.K.4
Lacro, J.P.5
Harris, M.J.6
-
17
-
-
0027501805
-
Does clozapine cause tardive dyskinesia?
-
Kane JM, Woerner MG, Pollack S, Safferman AZ, Lieberman JA. 1993. Does clozapine cause tardive dyskinesia? J Clin Psychiatry 54:327-330. (Pubitemid 23322379)
-
(1993)
Journal of Clinical Psychiatry
, vol.54
, Issue.9
, pp. 327-330
-
-
Kane, J.M.1
Woerner, M.G.2
Pollack, S.3
Safferman, A.Z.4
Lieberman, J.A.5
-
18
-
-
0033994522
-
Tardive dyskinesia is associated with impaired retrieval from long-term memory: The Curacao Extrapyramidal Syndrome Study IV
-
Krabbendam L, van Harten PN, Picus I, Jolles J. 2000. Tardive dyskinesia is associated with impaired retrieval from long-term memory: the Curacao Extrapyramidal Syndrome Study IV. Schizophr Res 42:41-46
-
(2000)
Schizophr Res
, vol.42
, pp. 41-46
-
-
Krabbendam, L.1
Van Harten, P.N.2
Picus, I.3
Jolles, J.4
-
19
-
-
0030612278
-
Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: Effects of chronic treatment with typical and atypical antipsychotic drugs
-
Lidow MS, Goldman-Rakic PS. 1997. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs. J Pharmacol Exp Ther 283:939-946.
-
(1997)
J Pharmacol Exp Ther
, vol.283
, pp. 939-946
-
-
Lidow, M.S.1
Goldman-Rakic, P.S.2
-
20
-
-
0025801091
-
The effects of clozapine on tardive dyskinesia
-
Lieberman JA, Saltz BL, Johns CA, Pollack S, Borenstein M, Kane J. 1991. The effects of clozapine on tardive dyskinesia. Br J Psychiatry 158:503-510.
-
(1991)
Br J Psychiatry
, vol.158
, pp. 503-510
-
-
Lieberman, J.A.1
Saltz, B.L.2
Johns, C.A.3
Pollack, S.4
Borenstein, M.5
Kane, J.6
-
22
-
-
33745309324
-
Aripiprazole-related tardive dyskinesia
-
Maytal G, Ostacher M, Stern TA. 2006. Aripiprazole-related tardive dyskinesia. CNS Spectr 11:435-439.
-
(2006)
CNS Spectr
, vol.11
, pp. 435-439
-
-
Maytal, G.1
Ostacher, M.2
Stern, T.A.3
-
23
-
-
0021645775
-
Effect of clozapine in severe tardive dyskinesia: A case report
-
Meltzer HY, Luchins DJ. 1984. Effect of clozapine in severe tardive dyskinesia: a case report. J Clin Psychopharmacol 4: 286-287.
-
(1984)
J Clin Psychopharmacol
, vol.4
, pp. 286-287
-
-
Meltzer, H.Y.1
Luchins, D.J.2
-
24
-
-
0032977410
-
The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
-
Meltzer HY, McGurk SR. 1999. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25:233-255.
-
(1999)
Schizophr Bull
, vol.25
, pp. 233-255
-
-
Meltzer, H.Y.1
McGurk, S.R.2
-
25
-
-
2442473932
-
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update
-
Miller AL, Hall CS, Buchanan RW, Buckley PF, Chiles JA, Conley RR, et al. 2004. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry 65:500-508.
-
(2004)
J Clin Psychiatry
, vol.65
, pp. 500-508
-
-
Miller, A.L.1
Hall, C.S.2
Buchanan, R.W.3
Buckley, P.F.4
Chiles, J.A.5
Conley, R.R.6
-
26
-
-
27744435853
-
Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trial
-
Miller DD, McEvoy JP, Davis SM, Caroff SN, Saltz BL, Chakos MH, et al. 2005. Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial. Schizophr Res 80:33-43
-
(2005)
Schizophr Res
, vol.80
, pp. 33-43
-
-
Miller, D.D.1
McEvoy, J.P.2
Davis, S.M.3
Caroff, S.N.4
Saltz, B.L.5
Chakos, M.H.6
-
27
-
-
0025239750
-
Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: An in vivo microdialysis study
-
Moghaddam B, Bunney BS. 1990. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem 54:1755-1760.
-
(1990)
J Neurochem
, vol.54
, pp. 1755-1760
-
-
Moghaddam, B.1
Bunney, B.S.2
-
28
-
-
0025167982
-
Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain
-
O'Dell SJ, La Hoste GJ, Widmark CB, Shapiro RM, Potkin SG, Marshall JF. 1990. Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain. Synapse 6:146-153.
-
(1990)
Synapse
, vol.6
, pp. 146-153
-
-
O'Dell, S.J.1
La Hoste, G.J.2
Widmark, C.B.3
Shapiro, R.M.4
Potkin, S.G.5
Marshall, J.F.6
-
29
-
-
0029938033
-
Clozapine versus typical antipsychotics: A retro-and prospective study of extrapyramidal side effects
-
Peacock L, Solgaard T, Lublin H, Gerlach J. 1996. Clozapine versus typical antipsychotics: a retro-and prospective study of extrapyramidal side effects. Psychopharmacology 124: 188-196.
-
(1996)
Psychopharmacology
, vol.124
, pp. 188-196
-
-
Peacock, L.1
Solgaard, T.2
Lublin, H.3
Gerlach, J.4
-
30
-
-
0038018122
-
The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis
-
Qing H, Xu H, Wei Z, Gibson K, Li XM. 2003. The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis. Eur J Neurosci 17: 1563-1570.
-
(2003)
Eur J Neurosci
, vol.17
, pp. 1563-1570
-
-
Qing, H.1
Xu, H.2
Wei, Z.3
Gibson, K.4
Li, X.M.5
-
31
-
-
0032935962
-
Receptor pharmacology of neuroleptics: Relation to clinical effects
-
Richelson E. 1999. Receptor pharmacology of neuroleptics: relation to clinical effects. J Clin Psychiatry 60:5-14.
-
(1999)
J Clin Psychiatry
, vol.60
, pp. 5-14
-
-
Richelson, E.1
-
33
-
-
0027665283
-
Cognitive dysfunction in schizophrenia: Organic vulnerability factor or state marker for tardive dyskinesia?
-
Waddington JL, O'Callaghan E, Larkin C, Kinsella A. 1993. Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia? Brain Cogn 23:56-70.
-
(1993)
Brain Cogn
, vol.23
, pp. 56-70
-
-
Waddington, J.L.1
O'Callaghan, E.2
Larkin, C.3
Kinsella, A.4
-
34
-
-
0022393159
-
Cognitive impairment in tardive dyskinesia
-
Wegner JT, Kane JM, Weinhold P, Woerner M, Kinon B, Lieberman J. 1985. Cognitive impairment in tardive dyskinesia. Psychiatry Res 16:331-337.
-
(1985)
Psychiatry Res
, vol.16
, pp. 331-337
-
-
Wegner, J.T.1
Kane, J.M.2
Weinhold, P.3
Woerner, M.4
Kinon, B.5
Lieberman, J.6
-
35
-
-
0033938971
-
Induction of metabolism-dependent and independent neutrophil apoptosis by clozapine
-
Williams DP, Pirmohamed M, Naisbitt DJ, Uetrecht JP, Park BK. 2000. Induction of metabolism-dependent and independent neutrophil apoptosis by clozapine. Mol Pharmacol 58: 207-216.
-
(2000)
Mol Pharmacol
, vol.58
, pp. 207-216
-
-
Williams, D.P.1
Pirmohamed, M.2
Naisbitt, D.J.3
Uetrecht, J.P.4
Park, B.K.5
-
36
-
-
0026666282
-
Gender differences in tardive dyskinesia: A critical review of the literature
-
Yassa R, Jeste DV. 1992. Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 18:701-715.
-
(1992)
Schizophr Bull
, vol.18
, pp. 701-715
-
-
Yassa, R.1
Jeste, D.V.2
-
37
-
-
77951673709
-
Prevalence of tarcive dyskinesia in inpatients using antipsycotics
-
Yoon JY, Oh DY, Choi JH. 2004. Prevalence of tarcive dyskinesia in inpatients using antipsycotics. Korean J Psychopharmacol 15:305-311.
-
(2004)
Korean J Psychopharmacol
, vol.15
, pp. 305-311
-
-
Yoon, J.Y.1
Oh, D.Y.2
Choi, J.H.3
|